January 27, 2010 (FinancialWire) — Integra LifeSciences (NASDAQ: IART) said that the first two-level surgery using the Paramount Pedicle Screw System for minimally invasive spine surgery under Integra Spine’s ownership was performed by Dr. Ali Araghi of the Texas Back Institute in Phoenix, Arizona, a designer of the Paramount system.

“The case went very smoothly, without any complications, accomplishing a two-level segmental posterior instrumentation,” said Dr. Araghi. “The patient presented with a prior multilevel decompression, and fusion at L2-L3, with subsequent post laminectomy syndrome and a scoliotic curve due to asymmetric collapse. I successfully used the Paramount system, from L2-L4, as posterior supplemental fixation to anterior column support placed thru a lateral trans-psoas approach. This type of corrective procedure, combined with the minimally invasive nature of the Paramount system, allowed me to make much smaller incisions, reducing disruption of the tissue and musculature at the treated level. This is a significant benefit for the patient.”

A unique feature of the Paramount Pedicle Screw System is the rod delivery method, wherein the rod is already attached to the polyaxial head, helping to streamline the fixation procedure and reduce the number of operative steps for the surgeon. The system also features a novel compression/distraction system and a robust rod reduction system. Additionally, the advanced Paramount screw delivery system uses a proprietary non-cannulated screw design with a K-wire guided tip for accurate screw placement and enhanced screw strength.

In the U.S. in 2009, an estimated 450,000 thoraco-lumbar fusions were performed to treat spinal disorders. Spine surgeons typically perform these procedures using highly invasive open techniques. The Paramount system gives surgeons a minimally invasive option to place the pedicle screws through a percutaneous tube. Patient benefits may include faster procedures, reduced blood loss, less tissue trauma, reduced postoperative pain and a shorter hospital stay.

The Paramount system is distributed through the Integra Spine independent distributor network. Integra Spine is a provider of fusion implants and orthobiologics used in spinal surgery. Visit www.integraspine.com for more information.

Integra LifeSciences Holdings Corp., a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year.

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.